Yokoyama, Keitaro http://orcid.org/0000-0002-6122-592X
Fukagawa, Masafumi
Shigematsu, Takashi
Akiba, Takashi
Yoshikawa, Ken
Tsuchiya, Akira
Kuwabara, Misato
Akizawa, Tadao
Funding for this research was provided by:
Ono Pharmaceutical
Article History
Received: 12 March 2020
Accepted: 16 July 2020
First Online: 20 August 2020
Compliance with ethical standards
:
: Keitaro Yokoyama has received honoraria from Torii Pharmaceutical Co., Ltd., ONO Pharmaceutical Co., Ltd., and Kyowa Kirin Co., Ltd. Masafumi Fukagawa has received honoraria from ONO Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., and Bayer Yakuhin Ltd.; research grants from Kyowa Kirin Co., Ltd.; and subsidies/donations from Kyowa Kirin Co., Ltd. Takashi Shigematsu has received honoraria from Torii Pharmaceutical Co., Ltd., ONO Pharmaceutical Co., Ltd., Bayer Yakuhin Ltd., Kissei Pharmaceutical Co., Ltd., and Kyowa Kirin Co., Ltd.; research grants from ONO Pharmaceutical Co., Ltd. and Fujiyakuhin Co., Ltd.; and subsidies/donations from ONO Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., and Chugai Pharmaceutical Co., Ltd. Takashi Akiba has nothing to disclose. Ken Yoshikawa, Akira Tsuchiya, and Misato Kuwabara are employees of ONO Pharmaceutical Co., Ltd. Tadao Akizawa has received honoraria from ONO Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Bayer Yakuhin Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Astellas Pharma Inc., and Fuso Pharmaceutical Industries, Ltd.; has received fees for serving on advisory boards for Japan Tobacco Inc., Kyowa Kirin Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Nipro Corporation; and has received author fees from Astellas Pharma Inc.
: This surveillance was conducted in accordance with Good Post-marketing Study Practice in Japan, for which the need for ethical approval is waived.
: Informed consent is not necessary for post-marketing surveillance using anonymized data collected in routine clinical practice for post-marketing evaluation of drug safety.